Pipeline Watch: ASCO Reveals Clinical Progress With Anticancers
Top-Line Results With Ozanimod, Remdesivir, Sulopenem
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
